Company Info
Phone(210) 698-5334
Year Established
2014
Ticker
BIAF
Exchange
NASDAQ
Contacts
Maria ZannesCEO
Vivienne I. Rebel, MD, PhD
CSO & CMO
Michael Dougherty, MBA, CPA
CFO
David Elzi, PhD
VP, Research
Timothy P. Zannes, JD
General Counsel
Xavier T. Reveles, MS, CG(ASCP)
VP, Operations
Company Description
bioAffinity Technologies addresses the urgent need for noninvasive, early-stage cancer diagnosis and targeted cancer treatment.